Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
We Can Medicines CoROCO:6929 +4.48%46 Days Inventory is 137.98 as of Dec. 2025, which is 17% above its 10-year median of 117.91. GuruFocus rates ROCO:6929 with a GF Score™ of 46/100 and a GF Value™ of NT$40.73 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,872 Consumer Packaged Goods companies, We Can Medicines Co ranks worse than 76.44% on this metric.
The historical rank and industry rank for We Can Medicines Co's Days Inventory or its related term are showing as below:
ROCO:6929'
s Days Inventory Range Over the Past 10 Years
Min: 106.15 Med: 117.91 Max: 143.78
Current: 143.58
During the past 6 years, We Can Medicines Co's highest Days Inventory was 143.78. The lowest was 106.15. And the median was 117.91.
ROCO:6929's Days Inventory is ranked worse than 76.44% of 1872
companies
in the Consumer Packaged Goods industry
Industry Median: 83.04
vs ROCO:6929: 143.58
We Can Medicines Co's Days Inventory
declined
from Dec. 2024 (140.36) to Dec. 2025 (137.98).
Inventory Turnover measures how fast the company turns over its inventory within a year.
We Can Medicines Co's Inventory Turnover for the
three
months ended in Dec. 2025 was 0.66.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
We Can Medicines Co's Inventory-to-Revenue for the
three
months ended in Dec. 2025 was 1.03.
We Can Medicines Co (ROCO:6929) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
We Can Medicines Co's Inventory Turnover for the
three
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
We Can Medicines Co's Inventory to Revenue for the
three
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
We Can Medicines Co Days Inventory Related Terms
We Can Medicines Co Days Inventory Historical Data
* Premium members only.
The historical data trend for We Can Medicines Co's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, We Can Medicines Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
We Can Medicines Co Days Inventory vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, We Can Medicines Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where We Can Medicines Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
We Can Medicines Co (ROCO:6929) has a Days Inventory of 137.98 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on We Can Medicines Co and its competitors. This is 17% above median its historical median of 117.91. Over the past decade, We Can Medicines Co's Days Inventory has ranged from 106.15 to 143.78. According to the industry distribution chart, We Can Medicines Co ranks #1431 out of 1872 companies in the Consumer Packaged Goods industry, placing it in the top 76.4%.
Is We Can Medicines Co's Days Inventory too high?
We Can Medicines Co's current Days Inventory of 137.98 is 17% above median its 10-year median of 117.91. Over the past 10 years, this metric has ranged from a low of 106.15 to a high of 143.78. The Consumer Packaged Goods industry median Days Inventory is 83.04. We Can Medicines Co's value of 137.98 is 66.2% above this industry median. Based on the distribution chart, We Can Medicines Co ranks #1431 out of 1872 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, We Can Medicines Co has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does We Can Medicines Co's Days Inventory compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, We Can Medicines Co ranks #1431 out of 1872 companies for Days Inventory. This places We Can Medicines Co in the lower half of its industry. The industry median Days Inventory is 83.04. We Can Medicines Co's value of 137.98 is 66.2% above this benchmark. Historically, We Can Medicines Co's own Days Inventory has ranged from 106.15 to 143.78 over the past decade. While the company's 10-year median is 117.91 vs. the industry median of 83.04, We Can Medicines Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Consumer Packaged Goods company?
The median Days Inventory among Consumer Packaged Goods companies is 83.04, based on 1,872 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. We Can Medicines Co's current Days Inventory of 137.98 is 66.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on We Can Medicines Co and its competitors. For the Consumer Packaged Goods industry, the median Days Inventory is 83.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. We Can Medicines Co's current Days Inventory is 137.98, which is 17% above median its own 10-year median of 117.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is We Can Medicines Co stock overvalued right now?
Based on GuruFocus' analysis, We Can Medicines Co (ROCO:6929) is currently considered Possible Value Trap. The stock's GF Value™ is NT$40.73, compared to a current price of NT$23.30 — trading 42.8% below its estimated fair value. The current Days Inventory is 137.98, which is 17% above median its 10-year median of 117.91 and 66.2% above the Consumer Packaged Goods industry median of 83.04. We Can Medicines Co's overall GF Score™ is 46/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For We Can Medicines Co (ROCO:6929), the current Days Inventory is 137.98 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is We Can Medicines Co (ROCO:6929) Overvalued in 2026?
Based on GuruFocus' analysis, We Can Medicines Co stock appears to be undervalued.
The current stock price of NT$23.30 is trading 42.8% below its estimated GF Value™ of NT$40.73.
GuruFocus considers We Can Medicines Co to be Possible Value Trap.
Key valuation signals for ROCO:6929:
Days Inventory: 137.98 (17% above median its 10-year median of 117.91)
GF Value™: NT$40.73 vs. price of NT$23.30 (42.8% below fair value)
Industry Position: 66.2% above the Consumer Packaged Goods median (#1431 of 1872)
No single metric tells the full story. See the ROCO:6929 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
We Can Medicines Co Ltd is a Taiwan-based company mainly engaged in the operation of chain cosmeceutical drugstores. The Company's main products include pharmaceuticals and health food, maternity and infant products, medical supplies, beauty cosmetics, and daily necessities.
46GF Score
Get the complete analysis for ROCO:6929
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6929 has been successfully added to your 
